(Q46339842)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18825538%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

title

Effectiveness of commercial inhibitors against subtype F HIV-1 protease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18825538%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18825538%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

author name string

Sandra Krauchenco

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18825538%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Nadia H Martins

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18825538%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Mario Sanches

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18825538%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

publication date

1 June 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18825538%20AND%20SRC:MED&resulttype=core&format=json

Journal of Enzyme Inhibition and Medicinal Chemistry

14 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18825538%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18825538%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18825538%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

page(s)

638-645

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18825538%20AND%20SRC:MED&resulttype=core&format=json

Estimated Global Distribution and Regional Spread of HIV-1 Genetic Subtypes in the Year 2000

14 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1080%2F14756360802321740

HIV-1: fifteen proteins and an RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756360802321740

Conserved folding in retroviral proteases: crystal structure of a synthetic HIV-1 protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756360802321740

Structure of complex of synthetic HIV-1 protease with a substrate-based inhibitor at 2.3 A resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756360802321740

X-ray analysis of HIV-1 proteinase at 2.7 A resolution confirms structural homology among retroviral enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756360802321740

Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: results of a global collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756360802321740

HIV-1 Protease and reverse-transcriptase mutations: correlations with antiretroviral therapy in subtype B isolates and implications for drug-resistance surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756360802321740

Structural mechanisms of HIV drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756360802321740

Structural basis of drug resistance for the V82A mutant of HIV-1 proteinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756360802321740

A major role for a set of non-active site mutations in the development of HIV-1 protease drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756360802321740

Mutational anatomy of an HIV-1 protease variant conferring cross-resistance to protease inhibitors in clinical trials. Compensatory modulations of binding and activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756360802321740

Non-active site changes elicit broad-based cross-resistance of the HIV-1 protease to inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756360802321740

Secondary mutations in the protease region of human immunodeficiency virus and virologic failure in drug-naive patients treated with protease inhibitor-based therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756360802321740

The HIV-1 protease as enzyme and substrate: mutagenesis of autolysis sites and generation of a stable mutant with retained kinetic properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756360802321740

Testing genotypic and phenotypic resistance in human immunodeficiency virus type 1 isolates of clade B and other clades from children failing antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756360802321740

Novel fluorogenic substrates for assaying retroviral proteases by resonance energy transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756360802321740

Kinetics of the reversible inhibition of enzyme-catalysed reactions by tight-binding inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756360802321740

Catalytic efficiency and vitality of HIV-1 proteases from African viral subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756360802321740

Rapid enzymatic test for phenotypic HIV protease drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756360802321740

Effect of point mutations on the kinetics and the inhibition of human immunodeficiency virus type 1 protease: relationship to drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756360802321740

Crystal structures of complexes of a peptidic inhibitor with wild-type and two mutant HIV-1 proteases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756360802321740

Low accumulation of L90M in protease from subtype F HIV-1 with resistance to protease inhibitors is caused by the L89M polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756360802321740

Structural characterization of B and non-B subtypes of HIV-protease: insights into the natural susceptibility to drug resistance development

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756360802321740

Kinetic characterization and cross-resistance patterns of HIV-1 protease mutants selected under drug pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756360802321740

Molecular basis of resistance to HIV-1 protease inhibition: a plausible hypothesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756360802321740

Comparing the accumulation of active- and nonactive-site mutations in the HIV-1 protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756360802321740

Development of a New Type of Protease Inhibitors, Efficacious against FIV and HIV Variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756360802321740

Thermodynamic Basis of Resistance to HIV-1 Protease Inhibition: Calorimetric Analysis of the V82F/I84V Active Site Resistant Mutant†

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756360802321740

10.1080/14756360802321740

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18825538%20AND%20SRC:MED&resulttype=core&format=json

release_plulumylwnfc3lgdwwoje5rtcu

14 January 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/plulumylwnfc3lgdwwoje5rtcu

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference